Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520552613> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- W1520552613 endingPage "214" @default.
- W1520552613 startingPage "205" @default.
- W1520552613 abstract "Introduction Among the early successes of allogeneic BMT were those achieved in the area of congenital immunodeficiencies. In certain diseases and certain donor–recipient combinations, over 90% of patients can be cured by allogeneic transplantation. Worldwide, over 3000 patients with congenital immunodeficiencies have been treated by allogeneic transplantation. The following table gives a list of the current indications. Patients with congenital immunodeficiencies generally manifest as severe infections within the first year of life. In the absence of a hematopoietic SCT or BMT, most severe immunodeficiencies are fatal. The European Society for Immunodeficiencies (ESID) in collaboration with the EBMT provides guidelines for the conditioning regimens in use for primary immunodeficiencies (www.esid.org and www.ebmt.org). For reviews related to BMT and congenital immunodeficiencies, see Buckley, 2003; Buckley et al., 1999; and Steward and Jarisch, 2005. Szabolcs et al. (2010) gave a very detailed overview of the primary immunodeficiencies treated by BMT/SCT. With the advent of genetic mapping, SCID is now increasingly classified on a genetic basis. This gives a more precise characterization of the immunological defects. Thus, it is becoming clear which types have the best cure rate, allowing the stratification of therapy. For example, patients with a mutation in the antigen receptor gene Artemis (resulting in a T-B- NK+ phenotype) were described as having a worse prognosis." @default.
- W1520552613 created "2016-06-24" @default.
- W1520552613 creator A5044583245 @default.
- W1520552613 creator A5052018750 @default.
- W1520552613 creator A5074770391 @default.
- W1520552613 date "2009-02-26" @default.
- W1520552613 modified "2023-10-14" @default.
- W1520552613 title "Therapeutic decision making in BMT/SCT for congenital immunodeficiencies" @default.
- W1520552613 cites W1986805336 @default.
- W1520552613 cites W1993302707 @default.
- W1520552613 cites W2034704801 @default.
- W1520552613 cites W2035594809 @default.
- W1520552613 cites W2095305931 @default.
- W1520552613 cites W2111158359 @default.
- W1520552613 cites W2128878002 @default.
- W1520552613 cites W2152461163 @default.
- W1520552613 cites W2330288813 @default.
- W1520552613 doi "https://doi.org/10.1017/cbo9780511575525.018" @default.
- W1520552613 hasPublicationYear "2009" @default.
- W1520552613 type Work @default.
- W1520552613 sameAs 1520552613 @default.
- W1520552613 citedByCount "0" @default.
- W1520552613 crossrefType "book-chapter" @default.
- W1520552613 hasAuthorship W1520552613A5044583245 @default.
- W1520552613 hasAuthorship W1520552613A5052018750 @default.
- W1520552613 hasAuthorship W1520552613A5074770391 @default.
- W1520552613 hasConcept C71924100 @default.
- W1520552613 hasConceptScore W1520552613C71924100 @default.
- W1520552613 hasLocation W15205526131 @default.
- W1520552613 hasOpenAccess W1520552613 @default.
- W1520552613 hasPrimaryLocation W15205526131 @default.
- W1520552613 hasRelatedWork W1506200166 @default.
- W1520552613 hasRelatedWork W2039318446 @default.
- W1520552613 hasRelatedWork W2048182022 @default.
- W1520552613 hasRelatedWork W2080531066 @default.
- W1520552613 hasRelatedWork W2604872355 @default.
- W1520552613 hasRelatedWork W2748952813 @default.
- W1520552613 hasRelatedWork W2899084033 @default.
- W1520552613 hasRelatedWork W2998699411 @default.
- W1520552613 hasRelatedWork W3032375762 @default.
- W1520552613 hasRelatedWork W3108674512 @default.
- W1520552613 isParatext "false" @default.
- W1520552613 isRetracted "false" @default.
- W1520552613 magId "1520552613" @default.
- W1520552613 workType "book-chapter" @default.